DocSun Biomedical Holdings

DocSun Biomedical Holdings is an AI-driven healthcare company focused on developing advanced diagnostic tools and therapeutic solutions. The company leverages artificial intelligence and machine learning to enhance early disease detection and personalized treatment plans, particularly through non-invasive methods. Their portfolio includes AI-based screening for infectious diseases like COVID-19, as well as research into oncology and cardiovascular health. DocSun aims to integrate digital health technologies with traditional biomedical research to improve patient outcomes globally. The company operates primarily as a technology provider for healthcare systems and diagnostic centers.